Especially after hematopoietic stem cell transplantation (HSCT), infections are a major factor in morbidity and mortality. Neutropenic diets have long been advised to prevent these infections despite the scant evidence. The results of a recent research evaluating this notion show no discernible difference between a nonrestrictive diet and infection rates, feeding outcomes, and the incidence of acute graft-versus-host disease.

Patients with previously untreated mantle cell lymphoma (MCL) have relied on autologous stem cell transplant (ASCT) for more than 20 years; the current standard of care entails high-dose cytarabine-containing chemoimmunotherapy, ASCT, and rituximab maintenance. A recent clinical trial’s findings, which revealed that FFS was superior to ASCT when ibrutinib medication was added, may change this.

A fully human IgG1 antibody that selectively binds to mutant CALR, INCA033989 demonstrated activity in cells from MPN patients and a mouse model of essential thrombocythemia. In the model, INCA033989 selectively decreased levels of mutant CALR-positive platelets, re-established normal megakaryopoiesis, and selectively targeted mutant CALR disease-initiating clones.

Today, it is possible to safely treat CML throughout pregnancy with little danger to the unborn child, as TKIs can now be safely administered during the later stages of pregnancy, according to new research. After beginning or continuing TKI therapy, a sizable majority of patients can be managed by observation alone, and disease control can be attained. IFN-α may be given in any trimester with little harm to the fetus if active treatment is necessary. Most essential, however, is a multidisciplinary strategy to offer clear and concise guidance to enable both the mother and the family to participate in the decision-making process.

Over the past ten years, there has been a significant amount of consolidation in the EHR sector. Over a decade ago, there were over 1,000 EHR vendors, according to KLAS Research. That number had fallen to about 400 as late as 2019. According to an examination of EHR purchasing activities that took place in 2021, Becker’s Hospital Review recently compiled a list of the top EHR platforms, sorted by share of the US hospital market.

Medicare cuts will complicate the lives and precarious health circumstances of the millions of Americans who depend on it while undermining the quality of care for numerous diseases. As a result, the 4.5% reduction to therapy providers under the Medicare Physician Fee Schedule in 2023 is causing great worry among seniors and healthcare professionals countrywide. The physical and occupational therapy professions would see reductions of about 9% by 2024 if this cut were to go into effect.